Investigation of antihypoxic properties of short peptides
Animal research · 2008
- What was studied
- Experimental hypobaric/prenatal hypoxia models
- Main finding
- The comparative report describes antihypoxic activity, with the largest effect for Pinealon in the tested model.
Study data at a glance
- Participants or experimental model
- Experimental hypobaric/prenatal hypoxia models
- Reported results
- The comparative report describes antihypoxic activity, with the largest effect for Pinealon in the tested model.
Study limitations and source details
Study limitations
- Model-specific ranking cannot be transferred to humans or occupational exposure protection.
- Full methods, adverse-event reporting and independent replication remain to be appraised.
Source details
Journal publication
Europe PMC indexed citation and abstract checked. Full original paper not reviewed.
Sources checked
Citation
Kozina LS. Investigation of antihypoxic properties of short peptides Advances in gerontology = Uspekhi gerontologii 21(1):61-67. PMID 18546825
Related compounds
Pinealon
A synthetic tripeptide, Glu–Asp–Arg (EDR). Researchers have examined its effects in neuronal aging models and measured functional outcomes in human performance studies.
Vesugen
A synthetic three-amino-acid peptide (Lys–Glu–Asp, or KED) studied in vascular and cell-aging research.
Vilon
A synthetic two-amino-acid peptide (Lys–Glu, or KE) studied in thymus, immune and tissue-repair research.
Epitalon
A synthetic tetrapeptide, Ala–Glu–Asp–Gly (AEDG, also called Epithalon), developed from pineal-gland research. Human studies examined melatonin secretion, circadian markers and retinal function.